We have recently become members of the Nanovac Consortium. The Nanovac consortium is a fast growing international network of research groups and SMEs led by the Medway School of Pharmacy, interested in developing nanoconjugates and vaccines in particular - but not exclusively - for the treatment of allergic and inflammatory diseases. We are aiming to attract Horizon 2020 funding to further develop our ideas for innovative treatments.
More information is available here.
The University of NottinghamThe Boots Science Building, University Park Nottingham, NG7 2RD
telephone:+44(0) 115 84 66073 email:franco.falcone@nottingham.ac.uk